Gain Therapeutics Inc.

NASDAQ: GANX · Real-Time Price · USD
1.73
0.19 (12.34%)
At close: Aug 15, 2025, 3:59 PM
1.76
1.73%
After-hours: Aug 15, 2025, 07:49 PM EDT

Gain Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-20.41M -22.27M -17.59M -13.89M
Depreciation & Amortization
84.07K 83.58K 64.17K 15.48K
Stock-Based Compensation
2.39M 3.26M 1.53M 839.37K
Other Working Capital
-1.36M 1.09M 444.52K 34.7K
Other Non-Cash Items
143.52K -383.19K -206.86K -34.13K
Deferred Income Tax
n/a n/a n/a 1.09M
Change in Working Capital
-1.08M 442.23K 1.51M -385.11K
Operating Cash Flow
-18.87M -18.87M -14.69M -12.37M
Capital Expenditures
-22.49K -15.36K -118.95K -94.21K
Cash Acquisitions
n/a n/a 14.66M n/a
Purchase of Investments
n/a -1.96M -17.74M n/a
Sales Maturities Of Investments
5M 12.19M 3.08M n/a
Other Investing Acitivies
n/a n/a -14.66M n/a
Investing Cash Flow
4.98M 10.22M -14.77M -94.21K
Debt Repayment
-90.88K -89.07K -78.77K -21.95K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-109.36K n/a n/a -841.27K
Financial Cash Flow
13.01M 12.64M -78.77K 41.77M
Net Cash Flow
-1.41M 4.49M -29.57M 29.41M
Free Cash Flow
-18.9M -18.88M -14.81M -12.46M